Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Cellectar Biosciences, Inc. | tm2114647d1_ex31-1.htm |
| 10-K/A - FORM 10-K/A - Cellectar Biosciences, Inc. | tm2114647d1_10ka.htm |
EXHIBIT 31.2
CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Dov Elefant, Chief Financial Officer, Cellectar Biosciences, Inc., certify that:
| 1. | I have reviewed this Amendment No. 1 to the annual report on Form 10-K/A of Cellectar Biosciences, Inc.; and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| /s/ Dov Elefant | |
| Date: April 30, 2021 | Dov Elefant |
| Chief Financial Officer |